nn_logo_rgb_blue_small(1)

About Us:

Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our con-viction that the formula for lasting success is to stay focused, think long-term, and do business in a fi-nancially, socially, and environmentally responsible way. With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs approximately 10,000 people throughout the country across more than 10 manufacturing, R&D and corporate locations in eight states plus Washington DC. For more information, visit novonordisk-us.com, Facebook, Instagram, and X.

Address:

800 Scudders Mill Road

Plainsboro, New Jersey 08536

Map It

Phone:

(609) 987-5800

Email:

UHKG@Novonordisk.com

Website:

http://novomedlink.com

Brief summary of content:

Please access our HCP resources at the webpages below for Sogroya and Norditropin.

https://www.sogroyapro.com
https://www.norditropinpro.com

If you have patients with questions about NovoCare® programs or affording their medications, contact NovoCare® at:

https://www.NovoCare.com

Help with Cost and Coverage of our Products:

https://www.novomedlink.com/growth-related-disorders/patient-support/access-affordability/support-savings.html

Questions about our products? Your local representatives are ready to help with clinical resources, patient educational materials and information on insurance support options.
(Intended for HCPs only)

https://www.novomedlink.com/growth-related-disorders/products/resources/novonordisk-representative.html

Explore facts and recommendations for pharmacological treatments for rare endocrine disorders. All content is intended for use by U.S. Healthcare Professionals only:

https://www.novonordiskmedical.com/therapeutic-areas/rare-endocrine-disorders/pharmacotherapies.html

Speak to a medical representative:

https://www.novonordiskmedical.com/submit-a-question.html

For general Novo Nordisk questions, please call 1-800-727-6500

For product inquiries, please call 1-800-727-6500

To report a side effect or product complaint, please call 1-800-727-6500.

Enter the MAP Spotlight Raffle